|
|
||||||||
Journal of General Virology, Vol 79, 2785-2793, Copyright © 1998 by Society for General Microbiology
ARTICLES |
SR Paludan, S Ellermann-Eriksen and SC Mogensen
Department of Medical Microbiology and Immunology, University of Aarhus, Aarhus C, Denmark.
Nitric oxide (NO), produced in interferon (IFN)-gamma-activated murine macrophages by the enzyme inducible nitric oxide synthase (iNOS), has been found to have antiviral properties. We have previously shown that herpes simplex virus type 2 (HSV-2) infection of macrophages synergistically enhances IFN-gamma-induced NO production, and we now extend these findings by providing evidence that virus-induced tumour necrosis factor (TNF)-alpha mediates activation of the transcription factor nuclear factor (NF)-kappaB, which in turn is responsible for the synergistic effect. HSV-2 infection and IFN-gamma stimulation of macrophages synergistically induced TNF-alpha secretion and nuclear translocation of NF-kappaB, which bound to a sequence corresponding to a kappaB site in the iNOS promoter. The effect of HSV-2 on NF-kappaB and NO production was eliminated when cells were treated with antibodies to TNF-alpha, and direct inhibition of NF-kappaB activation with pyrrolidinedithiocarbamate (PDTC) also blocked the effect of HSV-2 infection on NO production. The effect of the NF-kappaB activation inhibitor was not mediated through inhibition of the production of interferon regulatory factor (IRF)-1 or of TNF-alpha itself, and a possible alternative mechanism of activation of NF-kappaB through virus- induced activation of the kinase PKR was also ruled out. Thus, our data indicate that NF-kappaB activation, through virus-induced autocrine TNF- alpha secretion, is responsible for the synergistic effect of HSV-2 infection on IFN-gamma-induced NO production, and that such activation might constitute a mechanism by which high-output NO production is targeted to infectious foci.
This article has been cited by other articles:
![]() |
M. Thapa and D. J. J. Carr Herpes Simplex Virus Type 2-Induced Mortality following Genital Infection Is Blocked by Anti-Tumor Necrosis Factor Alpha Antibody in CXCL10-Deficient Mice J. Virol., October 15, 2008; 82(20): 10295 - 10301. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vila-del Sol, M. D. Diaz-Munoz, and M. Fresno Requirement of tumor necrosis factor {alpha} and nuclear factor-{kappa}B in the induction by IFN-{gamma} of inducible nitric oxide synthase in macrophages J. Leukoc. Biol., January 1, 2007; 81(1): 272 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Jones and A. M. Arvin Inhibition of the NF-{kappa}B Pathway by Varicella-Zoster Virus In Vitro and in Human Epidermal Cells In Vivo. J. Virol., June 1, 2006; 80(11): 5113 - 5124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jaramillo, P. H. Naccache, and M. Olivier Monosodium Urate Crystals Synergize with IFN-{gamma} to Generate Macrophage Nitric Oxide: Involvement of Extracellular Signal-Regulated Kinase 1/2 and NF-{kappa}B J. Immunol., May 1, 2004; 172(9): 5734 - 5742. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jaramillo, D. C. Gowda, D. Radzioch, and M. Olivier Hemozoin Increases IFN-{gamma}-Inducible Macrophage Nitric Oxide Generation Through Extracellular Signal-Regulated Kinase- and NF-{kappa}B-Dependent Pathways J. Immunol., October 15, 2003; 171(8): 4243 - 4253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Melchjorsen and S. R. Paludan Induction of RANTES/CCL5 by herpes simplex virus is regulated by nuclear factor {kappa}B and interferon regulatory factor 3 J. Gen. Virol., September 1, 2003; 84(9): 2491 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Malmgaard and S. R. Paludan Interferon (IFN)-{alpha}/{beta}, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-{gamma} during infection with herpes simplex virus type 2 J. Gen. Virol., September 1, 2003; 84(9): 2497 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Paludan and S. C. Mogensen Virus-Cell Interactions Regulating Induction of Tumor Necrosis Factor Alpha Production in Macrophages Infected with Herpes Simplex Virus J. Virol., November 1, 2001; 75(21): 10170 - 10178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Paludan Requirements for the Induction of Interleukin-6 by Herpes Simplex Virus-Infected Leukocytes J. Virol., September 1, 2001; 75(17): 8008 - 8015. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ellermann-Eriksen and V. Kruys Expression of TNF-{alpha} by Herpes Simplex Virus-Infected Macrophages Is Regulated by a Dual Mechanism: Transcriptional Regulation by NF-{kappa}B and Activating Transcription Factor 2/Jun and Translational Regulation Through the AU-Rich Region of the 3' Untranslated Region J. Immunol., August 15, 2001; 167(4): 2202 - 2208. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Mogensen and S. R. Paludan Molecular Pathways in Virus-Induced Cytokine Production Microbiol. Mol. Biol. Rev., March 1, 2001; 65(1): 131 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Franchini, C. Abril, C. Schwerdel, C. Ruedl, M. Ackermann, and M. Suter Protective T-Cell-Based Immunity Induced in Neonatal Mice by a Single Replicative Cycle of Herpes Simplex Virus J. Virol., January 1, 2001; 75(1): 83 - 89. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |